MSI1 and cancer: One notable exception was kidney cancer (KIRC), wherenon-silent mutations in Msi1 were significantly overrepresented,detectable in 9% of tumors (ranked in the 99th percentile of mutations pergene in this cancer) (Figure 1—figuresupplement 1A).